» Articles » PMID: 12472795

Muscle Atrophy in Patients Receiving Hemodialysis: Effects on Muscle Strength, Muscle Quality, and Physical Function

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2002 Dec 11
PMID 12472795
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dialysis patients are less active and have reduced functional capacity compared to individuals with normal renal function. Muscle atrophy and weakness may contribute to these problems. This investigation was undertaken to quantify the extent of atrophy in the lower extremity muscles, to determine whether defects in muscle specific strength (force per unit mass) or central nervous system (CNS) activation are present, and to assess the relationship between muscle size and physical performance in a group of patients on hemodialysis.

Methods: Thirty-eight dialysis subjects (aged 55 +/- 15 years) and nineteen healthy sedentary controls (aged 55 +/- 13 years) were enrolled. Magnetic resonance imaging of the lower leg was used to determine the total cross-sectional area (CSA) and the area of contractile and non-contractile tissue of the ankle dorsiflexor muscles. Isometric dorsiflexor strength was measured during a maximal voluntary contraction with and without superimposed tetanic stimulation (N = 22 for dialysis subjects, N = 12 for controls). Physical activity was measured by accelerometry, and gait speed was recorded as a measure of physical performance.

Results: Dialysis subjects were weaker, less active, and walked more slowly than controls. Total muscle compartment CSA was not significantly different between dialysis subjects and controls, but the contractile CSA was smaller in the dialysis patients even after adjustment for age, gender, and physical activity. Central activation and specific strength were normal. Gait speed was correlated with contractile CSA.

Conclusions: Significant atrophy and increased non-contractile tissue are present in the muscle of patients on hemodialysis. The relationship between contractile area and strength is intact in this population. Muscle atrophy is associated with poor physical performance. Thus, interventions to increase physical activity or otherwise address atrophy may improve performance and quality of life.

Citing Articles

Myosteatosis is associated with adiposity, metabolic derangements and mortality in patients with chronic kidney disease.

Sabatino A, Cordeiro A, Prado C, Lindholm B, Stenvinkel P, Avesani C Eur J Clin Nutr. 2025; .

PMID: 39748057 DOI: 10.1038/s41430-024-01551-4.


A systematic review and meta-analysis investigating the impact of exercise interventions on heart rate variability in hemodialysis patients.

Dos Santos Disessa H, Monteiro P, da Silva Zacharias V, da Costa Rosa C, Monteiro H Sci Rep. 2024; 14(1):30818.

PMID: 39730561 PMC: 11681022. DOI: 10.1038/s41598-024-81217-0.


Association of plant and animal protein intake with sleep quality and quality of life in hemodialysis patients: a multicenter cross-sectional study.

Jafari Maskouni S, Bavi Behbahani H, Alipour M, Javid A, Fayazfar F, Tofighzadeh P Front Nutr. 2024; 11:1458560.

PMID: 39600724 PMC: 11588489. DOI: 10.3389/fnut.2024.1458560.


Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.

Heitman K, Bollenbecker S, Bradley J, Czaya B, Fajol A, Thomas S Int J Mol Sci. 2024; 25(17).

PMID: 39273260 PMC: 11395169. DOI: 10.3390/ijms25179308.


Myosteatosis: an underrecognized risk factor for mortality in non-dialysis chronic kidney disease patients.

Donato B, Almeida R, Raimundo M, Velho S, Primitivo A, Correia F J Nephrol. 2024; 37(8):2307-2315.

PMID: 39133463 DOI: 10.1007/s40620-024-02042-2.